This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Major, M. E.
Right arrow Articles by Feinstone, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Major, M. E.
Right arrow Articles by Feinstone, S. M.

 Previous Article  |  Next Article 

Journal of Virology, April 1999, p. 3317-3325, Vol. 73, No. 4
0022-538X/99

Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus

Marian E. Major,1 Kathleen Mihalik,1 Javier Fernandez,1 Jessica Seidman,1 David Kleiner,2 Alexander A. Kolykhalov,3 Charles M. Rice,3 and Stephen M. Feinstone1,*

Laboratory of Hepatitis Research, Center for Biologics Evaluation and Research, Food and Drug Administration,1 and National Cancer Institute, National Institutes of Health,2 Bethesda, Maryland 20892, and Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, Missouri 631103

Received 2 November 1998/Accepted 29 December 1998

Two chimpanzees (Ch1535 and Ch1536) became infected with hepatitis C virus (HCV) following intrahepatic inoculation with RNA transcribed from a full-length cDNA clone of the virus. Both animals were persistently infected and have been followed for 60 weeks. They showed similar responses to infection, with transient liver enzyme elevations and liver inflammatory responses, which peaked at weeks 17 (Ch1535) and 12 (Ch1536) postinoculation (p.i.). Antibody responses to structural and nonstructural proteins were first detected at weeks 13 (Ch1535) and 10 (Ch1536) p.i. Serum RNA titers increased steadily during the first 10 to 13 weeks but decreased sharply in both animals following antibody and inflammatory responses. Despite direct evidence of humoral immune responses to multiple viral antigens, including hypervariable region 1 (HVR1), both animals remained chronically infected. Detailed sequence analysis of serum HCV RNA revealed no change in the majority HVR1 sequence in Ch1535 and a single-amino-acid mutation in Ch1536, with very little clonal variation in either animal. Full-length genome analysis at week 60 revealed several amino acid substitutions localized to antigens E1, E2, p7, NS3, and NS5. Of these, 55.6 and 40% were present as the majority sequence in serum RNA isolated at week 26 p.i. (Ch1535) and week 22 p.i. (Ch1536), respectively, and could represent immune escape mutations. Mutations accumulated at a rate of 1.57 × 10-3 and 1.48 × 10-3 nucleotide substitutions/site/year for Ch1535 and Ch1536, respectively. Taken together, these data indicate that establishment of a persistent HCV infection in these chimpanzees is not due to changes in HVR1; however, the possibility remains that mutations arising in other parts of the genome contributed to this persistence.


* Corresponding author. Mailing address: Division of Viral Products, CBER/FDA, Bldg. 29A, Rm. 1D14, HFM 448, 8800 Rockville Pike, Bethesda, MD 20892. Phone: (301) 827-1880. Fax: (301) 402-5585. E-mail: feinstone{at}cber.fda.gov.


Journal of Virology, April 1999, p. 3317-3325, Vol. 73, No. 4
0022-538X/99



This article has been cited by other articles:

  • Sakai, A., Takikawa, S., Thimme, R., Meunier, J.-C., Spangenberg, H. C., Govindarajan, S., Farci, P., Emerson, S. U., Chisari, F. V., Purcell, R. H., Bukh, J. (2007). In Vivo Study of the HC-TN Strain of Hepatitis C Virus Recovered from a Patient with Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) Are Infectious in Chimpanzees but Not in Huh7.5 Cells. J. Virol. 81: 7208-7219 [Abstract] [Full Text]  
  • Gehring, A. J., Sun, D., Kennedy, P. T. F., Nolte-'t Hoen, E., Lim, S. G., Wasser, S., Selden, C., Maini, M. K., Davis, D. M., Nassal, M., Bertoletti, A. (2007). The Level of Viral Antigen Presented by Hepatocytes Influences CD8 T-Cell Function. J. Virol. 81: 2940-2949 [Abstract] [Full Text]  
  • McMullan, L. K., Grakoui, A., Evans, M. J., Mihalik, K., Puig, M., Branch, A. D., Feinstone, S. M., Rice, C. M. (2007). Evidence for a functional RNA element in the hepatitis C virus core gene. Proc. Natl. Acad. Sci. USA 104: 2879-2884 [Abstract] [Full Text]  
  • Lazaro, C. A., Chang, M., Tang, W., Campbell, J., Sullivan, D. G., Gretch, D. R., Corey, L., Coombs, R. W., Fausto, N. (2007). Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes. Am. J. Pathol. 170: 478-489 [Abstract] [Full Text]  
  • Shin, E.-C., Protzer, U., Untergasser, A., Feinstone, S. M., Rice, C. M., Hasselschwert, D., Rehermann, B. (2005). Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C. J. Virol. 79: 13412-13420 [Abstract] [Full Text]  
  • Kato, N., Nakamura, T., Dansako, H., Namba, K., Abe, K.-i., Nozaki, A., Naka, K., Ikeda, M., Shimotohno, K. (2005). Genetic variation and dynamics of hepatitis C virus replicons in long-term cell culture. J. Gen. Virol. 86: 645-656 [Abstract] [Full Text]  
  • Fernandez, J., Taylor, D., Morhardt, D. R., Mihalik, K., Puig, M., Rice, C. M., Feinstone, S. M., Major, M. E. (2004). Long-Term Persistence of Infection in Chimpanzees Inoculated with an Infectious Hepatitis C Virus Clone Is Associated with a Decrease in the Viral Amino Acid Substitution Rate and Low Levels of Heterogeneity. J. Virol. 78: 9782-9789 [Abstract] [Full Text]  
  • Nam, J.-H., Faulk, K., Engle, R. E., Govindarajan, S., St. Claire, M., Bukh, J. (2004). In Vivo Analysis of the 3' Untranslated Region of GB Virus B after In Vitro Mutagenesis of an Infectious cDNA Clone: Persistent Infection in a Transfected Tamarin. J. Virol. 78: 9389-9399 [Abstract] [Full Text]  
  • Logvinoff, C., Major, M. E., Oldach, D., Heyward, S., Talal, A., Balfe, P., Feinstone, S. M., Alter, H., Rice, C. M., McKeating, J. A. (2004). Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 101: 10149-10154 [Abstract] [Full Text]  
  • Martin, A., Bodola, F., Sangar, D. V., Goettge, K., Popov, V., Rijnbrand, R., Lanford, R. E., Lemon, S. M. (2003). Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA. Proc. Natl. Acad. Sci. USA 100: 9962-9967 [Abstract] [Full Text]  
  • Wodarz, D. (2003). Hepatitis C virus dynamics and pathology: the role of CTL and antibody responses. J. Gen. Virol. 84: 1743-1750 [Abstract] [Full Text]  
  • Nascimbeni, M., Mizukoshi, E., Bosmann, M., Major, M. E., Mihalik, K., Rice, C. M., Feinstone, S. M., Rehermann, B. (2003). Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees. J. Virol. 77: 4781-4793 [Abstract] [Full Text]  
  • Bukh, J., Pietschmann, T., Lohmann, V., Krieger, N., Faulk, K., Engle, R. E., Govindarajan, S., Shapiro, M., St. Claire, M., Bartenschlager, R. (2002). Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc. Natl. Acad. Sci. USA 99: 14416-14421 [Abstract] [Full Text]  
  • Major, M. E., Mihalik, K., Puig, M., Rehermann, B., Nascimbeni, M., Rice, C. M., Feinstone, S. M. (2002). Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge. J. Virol. 76: 6586-6595 [Abstract] [Full Text]  
  • Mizukoshi, E., Nascimbeni, M., Blaustein, J. B., Mihalik, K., Rice, C. M., Liang, T. J., Feinstone, S. M., Rehermann, B. (2002). Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies. J. Virol. 76: 6093-6103 [Abstract] [Full Text]  
  • Sulkowski, M. S., Ray, S. C., Thomas, D. L. (2002). Needlestick Transmission of Hepatitis C. JAMA 287: 2406-2413 [Abstract] [Full Text]  
  • Ikeda, M., Yi, M., Li, K., Lemon, S. M. (2002). Selectable Subgenomic and Genome-Length Dicistronic RNAs Derived from an Infectious Molecular Clone of the HCV-N Strain of Hepatitis C Virus Replicate Efficiently in Cultured Huh7 Cells. J. Virol. 76: 2997-3006 [Abstract] [Full Text]  
  • Sun, J., Bodola, F., Fan, X., Irshad, H., Soong, L., Lemon, S. M., Chan, T.-S. (2001). Hepatitis C Virus Core and Envelope Proteins Do Not Suppress the Host's Ability To Clear a Hepatic Viral Infection. J. Virol. 75: 11992-11998 [Abstract] [Full Text]  
  • Sbardellati, A., Scarselli, E., Verschoor, E., De Tomassi, A., Lazzaro, D., Traboni, C. (2001). Generation of infectious and transmissible virions from a GB virus B full-length consensus clone in tamarins. J. Gen. Virol. 82: 2437-2448 [Abstract] [Full Text]  
  • Sewell, A. K., Price, D. A., Oxenius, A., Kelleher, A. D., Phillips, R. E. (2000). Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus: Control and Escape. Stem Cells 18: 230-244 [Abstract] [Full Text]  
  • Ray, S. C., Mao, Q., Lanford, R. E., Bassett, S., Laeyendecker, O., Wang, Y.-M., Thomas, D. L. (2000). Hypervariable Region 1 Sequence Stability during Hepatitis C Virus Replication in Chimpanzees. J. Virol. 74: 3058-3066 [Abstract] [Full Text]  
  • Smith, D. B., Basaras, M., Frost, S., Haydon, D., Cuceanu, N., Prescott, L., Kamenka, C., Millband, D., Sathar, M. A., Simmonds, P. (2000). Phylogenetic analysis of GBV-C/hepatitis G virus. J. Gen. Virol. 81: 769-780 [Abstract] [Full Text]  
  • Liang, T. J., Rehermann, B., Seeff, L. B., Hoofnagle, J. H. (2000). Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C. ANN INTERN MED 132: 296-305 [Abstract] [Full Text]  
  • Arichi, T., Saito, T., Major, M. E., Belyakov, I. M., Shirai, M., Engelhard, V. H., Feinstone, S. M., Berzofsky, J. A. (2000). Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model. Proc. Natl. Acad. Sci. USA 97: 297-302 [Abstract] [Full Text]  
  • Sbardellati, A., Scarselli, E., Tomei, L., Kekulé, A. S., Traboni, C. (1999). Identification of a Novel Sequence at the 3' End of the GB Virus B Genome. J. Virol. 73: 10546-10550 [Abstract] [Full Text]